Robin L. Smith - Insider Trading & Ownership

Entity
Individual
Location
C/O Phase III Medical, Inc., 330 South Service Road, Suite 120, Melville, NY
Summary
The estimated net worth of Robin L. Smith is at least $247K dollars as of June 16, 2023. Robin L. Smith is the Director of Sorrento Therapeutics, Inc. and owns shares of Sorrento Therapeutics, Inc. (SRNE) stock worth about $189K. Robin L. Smith is the Director of Celularity Inc and owns shares of Celularity Inc (CELU) stock worth about $58.8K.
All Insider Reports
All Insider Reports

Ownership of Robin L. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRNE Sorrento Therapeutics, Inc. Director $189K Sep 3, 2021
CELU, CELUW Celularity Inc Director $58.8K Jun 14, 2023
WAVS, WAVSU Western Acquisition Ventures Corp. Director Jan 11, 2022

Insider Transactions Reported by Robin L. Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.